Company profile: Helicon Therapeutics
1.1 - Company Overview
Company description
- Provider of therapeutics to treat disorders of cognition, developed through understanding the genetic basis of long-term memory formation; originating from the neuroscience program at Cold Spring Harbor Laboratory.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Helicon Therapeutics
Aruna Bio
HQ: United States
Website
- Description: Provider of neural exosome-based therapies for central nervous system and neurodegenerative disorders; developer of AB126, a therapeutic neural cell-derived exosome that crosses the blood-brain barrier to reduce neuro-inflammation, promote neuro-protection, and stimulate neuro-regeneration, plus a CNS therapeutic platform and pipeline; also conducts research in stem cells, neural stem cells, and drug toxicity assays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aruna Bio company profile →
Noema Pharma
HQ: Switzerland
Website
- Description: Provider of biotech therapies addressing disabling symptoms in orphan conditions of the brain and nervous system, with a pipeline including Phase 2b trials for childhood-onset fluency disorder (stuttering), tuberous sclerosis complex (seizures) and trigeminal neuralgia (severe pain), a Phase 2a trial in Tourette syndrome (involuntary tics), and a Phase 2-ready triple reuptake inhibitor for atypical depression and binge eating disorder.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noema Pharma company profile →
Psyadon
HQ: United States
Website
- Description: Provider of discovery and development of new treatments for serious psychiatric and neurological diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Psyadon company profile →
Neuronex
HQ: United States
Website
- Description: Provider of development-stage pharmaceutical drug development focused on treatments for central nervous system (CNS) diseases and disorders. Combines clinical expertise with thorough knowledge of the drug development process in a nimble, entrepreneurial environment to achieve rapid success in obtaining approvals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neuronex company profile →
Adolor
HQ: United States
Website
- Description: Provider of biopharmaceutical discovery, development and commercialization focused on prescription pain and pain-management products. Offers ENTEREG (alvimopan), an FDA-approved product indicated to accelerate upper and lower gastrointestinal recovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adolor company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Helicon Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Helicon Therapeutics
2.2 - Growth funds investing in similar companies to Helicon Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Helicon Therapeutics
4.2 - Public trading comparable groups for Helicon Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →